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A CONNaECTION between the process of cell proliferation and the increase in
tissue /-glucuronidase has been suggested by Kerr and Levvy (1947) and Levvy,
Kerr and Campbell (1948). Fishman (1947) and McDonald and Odell (1947;
Odell and McDonald, 1948) have investigated the changes of serum /-glucuro-
nidase activity in human pregnancy and Fishman (1947), Fishman and Anlyan
(1947a, 1947b) and Fishman, Anlyan and Gordon (1947) have shown that 13-
glucuronidase is present in enhanced amounts in human and animal cancer tissues.
The /-glucuronidase activity of body fluids has been investigated by several
workers in the hope of developing a method of diagnosis or prognosis of cancer.
The /-glucuronidase activity of blood serum, ascitic and pleural fluids (Fishman,
Markus, Page, Pfeiffer and Homburger, 1950), spinal and ventricular fluid (Anlyan
and Starr, 1952) and of vaginal fluids (Fishman, Kasdon and Homburger, 1950)
has been estimated in patients suffering from various forms of cancer especially
cancer of the breast and cervix.
Boyland, Wallace and Williams, (1955a, 1955b) have shown that cancer of
the bladder is associated with high fl-glucuronidase levels in the urine, serum and
bladder tissue. The present work deals with the urinary /-glucuronidase values
ofcases ofcancer ofsites other than the bladder. All the patients were in hospital,
on balanced diets, and all the specimens were collected before any operative
procedure was undertaken.
EXPERIMENTAL
The urine was collected in 2-litre vessels containing thymol dissolved in benzene
(10 ml. of 20 per cent solution). Individual 24-hour specimens were measured
and their pH and specific gravity determined. Samples were centrifuged at
450 g. for 15 minutes and the supernatant examined generally within 24 hours of
collection being completed.
The estimation offi-glucuronidase activity in urine
The method used was essentially that ofTalalay, Fishman and Huggins (1946)
which has been modified for routine analysis (Boyland, Wallace and Williams,
1955). The method has been further modified by increasing the strength of the
acetate buffer (pH 4.5) since, especially in the case of grossly infected urine, the
urine is sometimes alkaline and therefore greater buffering power is necessaryENZYME ACTIVITY IN RELATION TO CANCER
in order to maintain constant pH. Table I shows the effect of various buffer
concentrations on the pH of five typical urine samples. The system previously
used (b) does not always bring the pH of the urine mixture within the required
limits of 4.3-4.8 (Boyland, Wallace and Williams, 1955) but, by using 0-2 M
acetate buffer (c) the required conditions can be established. Under these
conditions neither the original alkaline buffer (d) nor a buffer of twice its strength
(e) is sufficiently strong to give a finalpH within the range 10.0-10.5. The system
(g) was finally selected as the one giving the most constant pH conditions.
TABLE I.-The Effect of Buffer Concentration on the pH of the Test Solution
(pH)
Specimen No. 1 2 3 4 5
a. Urine alone6. 30 5.20 5 70 7.00 5.95
b. Urine + substrate +- 0 1 M acetatebuffer . . 485 4-65 5-00 5-25 4.85
c. Urine + substrate + 0 2 M acetate buffer . . 4-50 455 4- 75 4.80 46.5
d. Urine + substrate + 0 2 M acetatebuffer + 0 4 Mglycinebuffer 9.50 8- 70 8.40 9
- 00 8 90
e. Urine + substrate + 0 2Macetatebuffer + 0 8 Mglycinebuffer 10 0 9.70 9.50 9.75 9.70
f. Urine + substrate + 0 2 Macetatebuffer + 10%Na2CO310H20 10- 1 10.0 9*7 10 0 9.95
g. Urin3 + substrate - 0 2Macetatebuffer + 10%Na2CO3 10 3 10-30 10.10 10- 30 10 25
(anhyd.)
The stability of the phenolphthalein colour at pH values above 9.5 has been
investigated as this colour tends to fade at high pH. The colour produced by a
series of standard enzyme solutions was investigated at pH values between 9.5
and 11-5 and found to be maximal between pH 10.2 and 10.6. The
phenolphthalein colour is stable for 2 hours within the pH range 10-10.5 so the
system (g) (Table I) is satisfactory and has been used throughout this work.
Urine (1 ml.) acetate buffer (1 ml.) (0-2 M, pH 4-5) and substrate solution
(1 ml. 0.05 per cent) were incubated in stoppered tubes for 18 hours at 37° in a
water bath, urine (1 ml.) was added to the blank and sodium carbonate solution
(1 ml. 10 per cent Na2CO3) was added to each. The tubes were centrifuged and
the duplicates read against the blank on a Unicam S.P. 500 spectrophotometer
at 550 m/a. The activity was expressed in units, 1 unit liberating 1 /ug. of
phenolphthalein per hour at 37°.
Owing to the modification of the method of estimation, the units are different
from those used previously (Boyland, Wallace and Williams, 1955), so that the
normal range (Table II) is now taken as 0.05-1*2 units/ml. of urine. Values in
the pH range of 5.0-7.0 are regarded as normal and deviation from this range is an
indication of infection of the urine. The specific gravity of the urine provides
a check on the complete collection of the specimen so that both pH and specific
gravity have been quoted for each specimen.
It has been suggested (Boyland et al., 1955; Boyland and Williams, 1956)
that both' the metabolism of tryptophan and the 8-glucuronidase activity of the
urine play a part in the production or maintenance of bladder tumours. The
amount oftryptophan in the diet might affectthe apparenturinary/,-glucuronidase
activity, because tryptophan metabolites conjugated with glucuronic acid might
act as competitive inhibitors. A number of specimens have been examined after
dosing the patients with 2 g. of L-tryptophan. Such specimens are indicated in
the tables by the presence of the letter T after the figure for urine volume. All
specific gravities are given in direct urinometer readings, thus a figure of 10
indicates a specific gravity of 1-010.
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TABLE II.-Normal Subjects
Urine Vol.
Age (ml.)
30 . 3250
· * ~1890
29 . 3500T
63 . 1300
68 . 1300
26 . 2560
72 . 1910
. 2770
48 . 2370T
68 . 1450
65 . 1670
58 . 1440
31 . 1550
21 . 1150
59 . 1830
50 . 5500
51 . 1830T
. 1100T
71 2520
31 . 1800T
60 . 2120T
pH
6-5
6'1
6-5
7 0
5'8
6-4
6'1
7 0
6 2
5.5
7'0
5.5
6'5
7'0
6*4
5.3
6'8
7'0
5-6
6*3
5*8
S.G.
11
12
10
22
06
06
14
15
08
12
20
15
10
09
3-glucuronidase
Units/mi.
0 05
0.14
0.17
0*32
0.35
0*36
0.36
0.44
0.59
0.60
0.60
0 74
0.80
0.81
0.87
0.89
0.90
0.93
1-0
1-1
1.2
Patients sufferingfrom cancer of the alimentary tract
The urinaryf-glucuronidase ofpatients suffering from cancer ofthe alimentary
tract varies with the site ofthe tumour. Thefl-glucuronidase values of 5 patients
out of 8 suffering from cancer of the stomach lie within the normal range and 3
are high (Table III). The mean value is 1.2 units which is the upper figure ofthe
normal range. Of6 cases ofargentaffinoma (TableIV) only onehas anabnormally
high activity and the average activity is 1.2. The fl-glucuronidase actitity of 5
out of 7 patients with cancer of the oesophagus (Table V) have values within the
normal limits but the average enzyme value is 1*5 units. All 5 of the cases of
cancer ofthe colon (Table VIa) have low ,-glucuronidase activity with an average
activity of 0.52 units and the urine volumes in these cases are also low. The
activities in the urines of five patients with cancer of the rectum Table VIb) are)
on or above the normal limit with an average value of 1-4 units.
TABLE III.-Patients Suffering From Cancer of the Stomach
Case Urine Vol.
No. Sex Age (ml.)
1 . M. . 48 . 1560
2 . M. . 42 . 2380
2450T
3 . M. . - . 1100
4 . M. . 56 . 1080
5 . M. . 36 . 1470
1930
1600
6 . M. . 39 . 900
7. M. . 65 . 1240
1120
8 . M. . 54 . 1460
1290 .
2040 .
pH
5.7
6-1
6-4
7 0
5*8
5*8
6-7
6-0
5-6
5.5
5*6
6*2
6*2 6-82
'
6- 8
S.G.
10
03
04
20
12
12
09
15
12
19
14
10
3-glucuronidase
Units/mi.
0·45
0 70
0.50
0-60
0 84
1.3
1.6
1-1
1-5
1-7
1*8
2-8
2.9
2*3
Caae
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Sex
M.
F.
M.
F.
M.
M.
M.
F.
M.
M.
M.
M.
M.
F.
M.
M.
M.
F.
M.
M.
M.
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TABLE IV.-Patients Sufferingfrom Argentaffinoma
Case Urine Vol
No. Sex. Age (mi.)
1 M. . - . 1800
2 . M. . 54 . 1900
3 . M. . .
4 . M. . 70 . 2020
1590
2320T
1700T
5 . M. . 65 . 735
6 . M. . 39 . 1025
pH
6.4
7.9
7.9
5-6
5-8
5'8
5.5
6.4
7.3
S.G.
11
12
09
11
TABLE V.-Patients Sufferingfrom Cancer of the Oesophagt
Case Urine Vol.
No. Sex Age (mi.)
1 . F. . -68 . 1890
2 . M. . 45 . 2050
3 . M. . 61 . 3320
5 . M. . 67 . 2220
1640
5 . M. . 39 . 890
6 . M. . 51 . 1530T
7 . M. . 61 . 370
450
Case
No.
pH
4 8
5.8 5.8 5-8 5.8
5-8
5 8 5.5 5.5 5.5
S.G.
08
09
08
12
12
24
26
3-g1ucuronidase
Units/mi.
0 7
0.8
0'9
1*1
0.8
0.9
0 7
1.0
3 2
(-glucuronidase
Units/mi.
0.30
0-80
1*1
1.0
1*4
1.2
1*3
4*2
4 2
TABLE VI.-Patients Sufferingfrom Cancer of the Colon or Rectum
Urine Vol. 3-glucuronidase
Sex Age (ml.) pH S.G. Units/ml.
(a) Colon
1 . M. . 66 . 1320
2 . F. . 53 . 890
1130
3 . M. . 47 . 1800
4 . F. . 58 . 1550
5 . M. . 68 . 700
(b) Rectum
1 . M. . 55 . 1250
2 . M. 72 . 1500
1800
3 . M. 65 . 1640
1310
4 . M. . 45 . 2100
1340
2370
5 . M. . 72 . 1450
5.6
6.4
6.4 5.4 5.2
5 2
6-0
5.5
5.6
6-0
7 0
6-1
6-4
5-5 5.5
12
08
09
08
10
10
15
12
15
20
06
10
0 27
0.46
0-28
0.54
0-65
0-77
1-1
1.1
1-2
1-5
1-4
1-3
1-7
1.0
1-6
Patients sufferingfrom cancer of the larynx
Of the 20 patients suffering with cancer of the vocal cord (Table VII) only 4
have f/-glucuronidase activities within the normal range, with a mean 1-7 units.
Of 11 patients suffering from cancer of the larynx but not cancer of the vocal
cord (Table VIII), 5 had values above the range of healthy subjects, the mean
value being 1-6 units.
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TABLE VII.-Patients Sufferingfrom Cancer of the Larynx
(a) Cancer of the Vocal Cord
Urine Vol
(ml.) pH
2750 . 55
1210T 5- .5
1100 . 5.5
2120 . 5.5
2290 . 5- .5
2630 . 6- 7
2380T . 6 8
1330 . 6 0
2590T . 7 2
2300 . 6 7
1490T . 5.5
1010 -
650 . 5.4
1770 . 58
2060 . 5- 9
710 . 7 0
1330T . 64
1700 . 5.5
1910T . 5.6
1130 5.5
710 . 6 0
540T . 5- .5
1080T . 58
2100 . 61
2320T . 5.5
660 . 5- 8
910T . 5- 8
710 . 7 0
2500 . 58
1600 . 6*4
740 . 56
850T . 5- .5
1270 . 7- .5
1260 . .7-3
890 . 61
900T . 5-6
3-glucuronidase
S.G. units/mi.
10 . 060
10 . 0-60
08 . 0 70
11 . 1-2
12 . 1.0
0-4 . 0-8
0.5 . 16
14 . 1-5
07 . 1.0
10 . 15
10 . 1.0
14
~- 1.5
21 . 15
08 . 1.5
18 . 1.6
10 . 1.5
19 . 17
12 . 1.3
14 . 17
29 . 1.5
15 . 23
17 . 18
11 . 17
10 . 16
15 . 25
15 . 24
18 . 1-6
. 2-9
11 . 1.1
23 . 2-5
28 . 3.1
10 . 3-4
13 . 3.7
18 . 41
14 . 3.2
TABLE VIII.-Patients Sufferingfrom Cancer of the Larynx
(b) Cancer of Sites other than Vocal Cord
Urine Vol.
Sex Age (ml.)
M. . 69 . 2350T
M. . 61 . 2340T
M. . 57 . 2660
2520T
M. . 56 . 2550T
F. . 84 . 940
1530T
M. . 39 . 890
M. . 51 . 1530T
M. . 64 . 2590T
M. . 62 . 1720T
M. . 54 1370T
M. . 57 . 860T
pH
5.5
6'1
7 0
7 0
6.7
6.0
5.8
5-8
5.5
6-4
5-8
6*9
7 0
S.G.
10
06
06
14
10
10
05
12
12
09
07
18
15
3-glucuronidase
Units/mi.
0.6
0 7
1.0
0 7
1.0
1.0
1.2
1-2
1*3
1.6
1-7
2.5
2.7
Sex
M.
M.
M.
M.
M.
M.
M.
F.
M.
M.
M.
M.
M.
M.
M.
Age
50
52
84
68
63
61
60
58
67
35
67
60
64
61
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
M.
F.
M.
M.
M.
38
61
55
83
73
Case
No.
1
2
3
4
5
6
7
8
9
10
11
124ENZYME ACTIVITY IN RELATION TO CANCER 125
Patients sufferingfrom cancer of the bronchus
Of 11 patients suffering from cancer of the bronchus (Table IX) 5 cases have
afl-glucuronidase activity within the normal range and the mean is 1-8 units.
TABLE IX.-Patients Sufferingfrom Cancer of the Bronchus
Case Urine Vol. P-glucuronidase
No. Sex Age (ml.) pH S.G. Units/ml.
1 . F. . 72 . 1700 . 6 0 . 10 . 0-50
1090 . 5.5 . 14 . 0 90
2 . M. . 49 . 2270 6 1 . 16 0 60
2800T . 7.0 . 06 . 11
3 . M. . 75 . 500 . - . - . 1 0
4 . M. . 57 . 1720 . 55 . 12 . 1.0
860 . 5.8 . 13 . 1- 2
5 . M. . 62 . 720 . 6 8 . 12 . 08
1200 . 60 . - . 15
6 . M. . - . 980 6.1 . 10 . 1.6
7 . M. . 66 . 1230 . 6 4 . 21 1 7
1980 . 6.4 . 24 . 1.8
8 . M. . 62 . 720 . 6.8 . 12 . 08
1200 . 6-0 . - . 1.5
9 . M. . 69 . 1400T . 6.4 . 15 . 24
10 . M. . 63 . 1400 . 7.0 . 14 . 2-4
11 . M. . 56 . 870 . 6.8 . 14 . 4-8
1370 68 . 14 . 4.9
Patients suffering from malignant blood diseases
The urinary /-glucuronidase activity of 8 out of 10 patients suffering from
leukaemia (Table Xa) was above the normal range with an average activity of
1.8 units. Cases 9 and 10 had pyrexia at the time of collection. Of 5 patients
suffering from Hodgkin's disease (Table Xb) 4 had activity above the normal
range and the average value is 2.5 units.
TABLE X.-Patients Sufferingfrom Malignant Blood Diseases
Case Urine Vol. l-glucuronidase
No. Sex Age (mi.) pH S.G. Units/mi.
(a) Leukaemia
1 M. . 44 . 1500 6 0 . - . 1 5
2 . M. 24 . 2200 . 5.7 - . 1 2
3 . M. 50 . 2500 6 7 . 09 . 12
2100 . 67 . 11 . 0 98
2500 . 58 67 . 1 9
4 . F. . 71 . 1850 7 0 10 1 7
1860T . 7.0 . 09 1 2
5 . F. . 76 . 1760 . 62 . - . 15
6 . F. . 44 . 1500 . 60 . - . 1 5
7 . M. . 70 . 1440 . 6.7 12 . 1.9
8 . F. . 16 . 1630 . 70 . 20 2 7
1410T . 7-4 . 24 . 24
9 . F. . 26 . 1680 5- 8 . 09 . 30
10 . M. . 38 . 2620 . 70 . 10 . 3- 4
(b) Hodykins Disease
1 . M. . 34 . 1890 . 6 4 . 07 . 0-50
1890 . 6.0 . 08 . 070
2 . M. . 48 . 720 . 5 8 . 20 1-3
1630 . 6.4 . 15 . 2'7
3 . M. . 42 . 2800 . 58 . 05 . 3-0
1800 . 61 . 12 . 2- 8
1200 . 6.0 . 10 . 2 7
4 . F. . 50 . 420T . 5.8 . 28 . 32
5 . M. . 63 . 1440 . 5.5 . 20 . 3.6
710 . 7.0 . - . 38126 E. BOYLAND, J. E. GASSON AND D. C. WILLIAMS
Patients sufferingfrom cancer of the breast
Of 15 patients suffering from cancer of the breast (Table XI), 8 are above the
normalrange ofactivity. Case 5 is a male with cancer ofthe breast. The average
fl-glucuronidase activity was 1.5 units.
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
TABLE XI.-Patients Sufferingfrom Cancer of the Breast
Urine Vol. P-glucuronisdase
Age (ml.) pH S.G. Units/mi.
55 . 1250 . 6.7 . 09 . 0 3
52 . 2500 . 5.8 . - . 0.8
47 . 1820 . 5.5 . - . 1.0
48 . 2400 . 6 9 . 10 . 1 2
42 1910T . 5.5 . 12 . 12
55 . 1200 . 5'5 . - . 1.2
55 1750 . 6'2 . - . 1-2
62 . 1570 . 4-8 . - . 1.5
53 1820 . 7 0 . 08 . 1.6
61 . 2000 . 6'5 . - . 1'9
1860 . 9.3 . 13 . 1 3
48 . 1140 . 6*0 . 18 . 2'2
1800T . 5-8 . 14 . 1-3
38 . 1375 . 6'5 . - . 1- 8
78 2020 . . - . · 2'2
54 . 960 . 4.5 . - . 2 5
63 . 1200 . 5'6 . 14 . 2 6
1030T . 5.6 . 12 . 2 5
Patients sufferingfrom cancer of the testicle
Of 15 patients suffering from cancer of the testicle (Table XII) 10 have f,-
glucuronidase values above the normal range. The average fl-glucuronidase
value is 1.5 units.
TABLE XII.-Patients Sufferingfrom Cancer of the Testicle
Case Urine Vol. P-glucuronidase
No. Age (ml.) pH S.G. Units/mi.
1 . 29 . 1800 . - - . 0 80
2 . 39 . 1400 . 5.4 . - . 085
3 . 45 . 610 . 5-8 . 24 . 1.0
4 . 35 . 1750 . 6-5 . - . 10.
5 . 55 . 1830 . 8.5 . 11 . 1'2
6 . 37 . 2190 . 7'6 . 14 . 0 8
2000T . 7 0 . 12 . 1'6
7 45 . 2100 . 6-1 . 15 . 1' 3
1340 . 6.4 . 20 . 1 7
2370 . 5.5 . 06 . 1.0
8 . 18 . 1500 . 5.5 . - . 1*5
900 . 6.0 . - . 1.3
9 . 31 . 2100 . 7.0 . - . 1'4
2100 . - . - . 14
2200 . 6-5 . - . 1'6
10 . 31 . 2100 . 7 0 . - . 1-4
11 . 18 . 1500 . 5-4 . - . 1*5
12 . 30 . 1500 . 5.5 . . 2-5
2550 . 5-8 . - . 1'2
13 . 68 . 1270 . 55 . 10 . 2'5
1330 . 5-5 . 10 . 2'2
1730 . 5-5 . 12 . 2'0
14 . 39 . 1250 . 5-9 . 18 . 1.8
450T . 5.5 . 12 . 4.0
15 . 29 . 1080 . - . 16 . 4.2
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Patients sufferingfrom cancer of the prostate
(a) Untreated patients.-Of 14 patients with cancer of the prostate examined
before treatment (Table XIII) one-half have values above normal range. The
average /-glucuronidase activity is 1.5 units/mi.
TABLE XIII.-Patients Sufferingfrom Cancer of the Prostate
(a) Untreated Patients
Urine Vol.
Age (mi.) pH
75 . 1700 . 6 0
67 . 1700 . 5.5
51 . 1850 . 6-1
62 . 1250 . 5- 6
58 1920 . 6- 5
79 . 1060 . 5-2
2000 . 5-2
1500 . 5-2
66 1100 .
68 1720 . 5-8
1490 . 6- 0
1100 . 5-8
1170T . 6 7
70 . 1910 . 5.7
1995 . 5- 8
57 . 2600 .
63 . 620 . 55
620T . 5.5
49 . 1290 . 7 0
1440T . 7- .1
70 . 1230 . 5.5
1640 . 5.5
1940 . 5- 8
66 . 1140 . 7 0
S.G.
12
08
12
17
08
12
10
08
10
15
13
14
20
22
10
11
12
09
10
06
3-glucuronidase
Units/ml.
0-55
0 79
0 95 1'0 1'0
1 .3
1-0
1'2
1.1
0.5
1.0
1 3
2'7
1-2
1.3
1'4
2'2
1-3
2-3
1.9
2-9
2-6
3*8
2'9
(b) Patients treated with stilboestrol for more than two years.-The mean f8-
glucuronidase activity of the urine of a group of 7 patients receiving treatment
with stilboestrol for more than two years (Table XIV) is 2.3 units and all were
above the normal range.
TABLE XIV.-Patients Sufferingfrom Cancer of the Prostate
(b) Patients Treated with Stilboestrolfor more tham Two Years
Urine Vol.
Age (mi.) pH
70 . 2070 5.5
2170 . 7-0
69 . 1100 . 6.1
1930 . 5-7
73 . 1590 . 6.9
6.9
66 . 970 . 5.8
1020 . 5.8
72 . 2580 . 2.3
1570 . 6*4
68 . 1360 . 7.0
1020 . 7.0
69 . 1650 . 7.0
1400 . 7 0
S.G.
13
13
21
11
20
13
15
13
12
20
15
19
17
15
3-glucuronidase
Units/nmil.
1-6
1.5
1-8
1.8
2-0
1*5
2-2
2.0
2.6
2-9
3.2
2.9
3.3
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Case
No.
1
2
3
4
5
6
7
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Patients sufferingfrom cancer of the thyroid
The results obtained from 7 patients with cancer of the thyroid (Table XV)
show only two of these patients had 8-glucuronidase activities greater than the
upper limit of normal and in both of these cases the patients had raised
temperatures at the time of collection of the specimen. The average i8-
glucuronidase activity of this group was 1-1 units.
TABLE XV.-Patients Sufferingfrom Cancer of the Thyroid
Case Urine Vol. P-glucuronidase
No. Sex Age (ml.) pH S.G. Units/ml.
1 . F. . 57 1850 . 5 5 . - . 0 35
1800 - . - 0 36
1900 . 5-8 . - . 0-31
2 . F. . 70 . 2500 . 60 . - . 045
1750 . 6-1 - . 0 58
2300 . 6-0 . . 038
3 M. 48 . 2120 7 0 . 09 . 0 35
1900 6-7 . 11 . 0-60
4 . F. . 68 . 1800 . 5.3 . - . 0-50
2050 - . - . 0 52
2010 . 5-6 15 . 0.50
5 F. . 1500 61 18 0 80
1675 . 61 22 0.50
6 F. - . 1130 . 6- 7 19 . 1.8
980 . 6- 7 . 09 . 1- 6
7 F. . 68 . 570 . 7 0 15 . 3.4
500 6-4 . 19 4-1
DISCUSSION
The/,8-glucuronidase excretion has been expressed as activityper unit volume of
urine but in all cases the volume of the 24-hour specimens of urine have also been
recorded so that total excretions of]]-glucuronidase per 24 hours may be obtained.
The method ofestimation has been modified so that even alkaline urine specimens,
previously discarded may now estimated, but in very alkaline conditions the
enzyme is not stable.
The urinary ,b-glucuronidase activities of patients varied considerably with
the site of the tumour but in no group of cases were all the results outside the
normal range. This suggests thatf,-glucuronidase activity could not be used as a
diagnostic method, although in some types of cancer such estimations might prove
useful for prognostic purposes.
The average urinary f-glucuronidase activity in cancer of various sites within
the alimentary tract is, in general, near the upper limit of normal but the activity
in cases of cancer of the colon is low. Cancer of the thyroid also produced a
decrease in urinary 8-glucuronidase activity but cases of cancer of larynx,
bronchus, oesophagus, prostate and testicle show an increased activity.
Cases ofleukaemia and ofHodgkin's disease also exhibit an increase in urinary
,-glucuronidase activity but in these cases there is generally an increase in the
patient's temperature, which is known to increase I-glucuronidase excretion
(Boyland and Williams, unpublished), so that the increased activity may be due
partly to this cause. The connection between malignant blood disease and blood
glucuronidase activity and the treatment of these patients with enzyme inhibitors
is being investigated.ENZYME ACTIVITY IN RELATION TO CANCER 129
SUMMARY
(1) The method previously used for the estimation of urinary /-glucuronidase
activity has been modified so that it may be applied to alkaline or concentrated
urine.
(2) Urinary f,-glucuronidase activities have been investigated in patients
suffering from cancer of the alimentary tract, larynx, breast, thyroid, bronchus,
testicle, and prostate and also in patients suffering from leukaemia and Hodgkin's
disease.
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